A shadow market for unapproved weight-loss medications is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.
Experimental Treatment Acquiring Traction Online
The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged weight-reducing effects. Viewers are encouraged to contact these profiles privately for source information, while also receiving discount codes.
Thriving Trade on Social Networks
Additionally, a robust trade exists on messaging services, where communities with thousands of participants share comparison images, administration instructions and assertions of rapid British shipping. Vendors promote the substance there before redirecting customers to WhatsApp for transactions.
Learning About The Experimental Drug
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could assist patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, doctors and chemists have cautions that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could result in users injecting substances of unknown origin.
Several experts stated the demand for retatrutide could be linked to the increasing price of approved slimming treatments such as Mounjaro.
Legal Position and Implementation
Selling retatrutide on social media or Telegram is illegal in the UK, as it is an unapproved drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.
Some influencers try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach medicines, advertising, and customer regulations, risking fines, legal action or prison.
Service Reaction and Material Elimination
According to the social media company, the platform has taken down problematic material and banned related keywords and search suggestions. The organization stated it was committed to maintaining the platform secure and investing in strengthening compliance measures.
Online Trading Activities
Investigations also found groups with up to 9,000 members marketing the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays groups with thousands of members, filled with photos of weight loss, glowing testimonials and step-by-step instructions for preparing or administering at home.
After moments of entering one community, a vendor shared WhatsApp details, where the majority of transactions occur. The vendor sent an guidebook and guaranteed shipping within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None asked about weight, medical conditions or past usage.
Product Information and Costs
Within these groups, posts show black plastic packages with postal service labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at home with sterile water, or pre-filled pens usually priced at 160 pounds for 20 milligrams. When asked how much time a pen should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.
Platform Moderation and Safety Measures
A representative for the messaging service said it actively monitored dangerous material on its service including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are injecting materials they cannot confirm. Although the science behind this drug is sound, these online versions may not contain what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in interest to recent cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, individuals are using online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.
Her staff has previously encountered individuals harmed by personal administration from unverified sources. “We understand the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”
Manufacturer Statement
A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a Lilly investigational substance not yet approved … may expose users to possibly serious health risks”.
